Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy

Tumori

Volumn 84, Issue 1, 1998, Pages 82-84

  Savelli, Giordano ^a   Chiti, Arturo ^a   Spinelli, Antonella ^a   Regalia, Enrico ^a   Mazzaferro, Vincenzo ^a   Castellani, Maria Rita ^a   Balzarini, Luca ^a   Musumeci, Renato ^a   Bombardieri, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Neuroendocrine tumors; Radionuclide imaging; Somatostatin receptors

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CARCINOID; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031898685     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169808400118     Document Type: Article

References (12)

1. Capella C., Heitz P.U., Höfler H., Solcia E., Klöppel G.: Revised classification of neuroendocrine tumours of the Lung, pancreas and gut. Virchows Archiv., 425: 547-560, 1995.
2. Jamar F., Fiasse R., Leners N., Pauwels S.: Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J. Nucl. Med., 36: 542-549, 1995.
3. 111In-pentetreotide for endocrine gastroenteropathic tumors. Horm. Metab. Res., 27 (Suppl): 28-35, 1993.
4. 123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med., 20: 716-731, 1993.
5. Kwekkeboom D.J., Krenning E.P., Baker W.H., Oei H.Y., Kooij P.P.M., Lamberts S.W.J.: Somatostatin analogue scintigrpahy in carcinoid tumors. Eur. J. Nucl. Med., 20: 283-292, 1993.
6. Lamberts S.W.J., Krenning E.P., Reubi J.C.: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev., 12:450-482, 1991.
7. Modlin I.M., Corneluis E., Lawton G.P.: Use of an isotopic somatostatin receptor probe to image gut endocrine tumors. Arch. Surg., 130: 367-374, 1995.
8. Schillaci O., Scopinaro F., Angeletti S., Tavolaro R., Danieli R., Annibale B., Gualdi G., Delle Fave G.: SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors. J. Nucl. Med., 37: 1452-1456, 1996.
9. Zimmer T., Ziegler K., Bäder M. , Fett U., Hamn B., Riecken E.O., Wiedenmann B.: Localization of neuroendocrine tumours of the upper gastrointestinal tract. Gut, 35: 471-475, 1994.
10. Sugimoto E., Lorelius L.E., Eriksson B., Oberg K.: Midgut carcinoid tumours. CT appearance. Acta radiologica, 36: 367-371, 1995.
11. Gorman B., Reading C.C.: Imaging of gastrointestinal neuroendocrine tumors. Semin. Ultrasound CT, 16: 331-341, 1995.
12. Zeman R.K., Zeiberg A.S., Davros W.J., Ascher S.M., Cooper C.J., Weltman D.I., Patt R., Garra B.S., Greigo D.L., Silverman P.M.: Routine helical CT of the abdomen: image quality considerations. Radiology, 189: 395-400, 1993.